PFBT
AGN

Parkside Financial Bank & Trust’s Allergan Inc AGN Stock Holding History

Parkside Financial Bank & Trust’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-908
Closed -$275K – 1130
2015
Q2 		$275K Buy
+908
New +$275K 0.15% 129

Other funds holding AGN

PAA
Peregrine Asset Advisers Portland, Oregon $371M AUM 41.36% 1-Year Est. Return
AWM
Altavista Wealth Management Asheville, North Carolina $496M AUM 20.88% 1-Year Est. Return
MMPW
Mitchell McLeod Pugh & Williams Mobile, Alabama $678M AUM 23.02% 1-Year Est. Return
ODCM
Old Dominion Capital Management Charlottesville, Virginia $467M AUM 25.94% 1-Year Est. Return
POA
Pergamon Offshore Advisors New York $91.8M AUM 13.29% 1-Year Est. Return
AAC
Asset Advisors Corp Augusta, Georgia $575M AUM 14.42% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
DY
Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return
AGA
Accuvest Global Advisors Provo, Utah $107M AUM 6.41% 1-Year Est. Return
LCM
Liberty Capital Management Birmingham, Michigan $582M AUM

Parkside Financial Bank & Trust's AGN Position: Q3 2015 in Review

Parkside Financial Bank & Trust sold out of Allergan Inc (AGN) in Q3 2015, closing a stake of 908 shares — an estimated $275K sold.

Parkside Financial Bank & Trust first reported a position in AGN in Q2 2015 and held it in 1 quarter. The position peaked at $275K in Q2 2015. 27 funds tracked by Wall St. Rank hold AGN as of Q3 2015.

  • Parkside Financial Bank & Trust reported no remaining Allergan Inc position as of Q3 2015 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 908 Allergan Inc shares in Q3 2015, an estimated $275K.
  • Parkside Financial Bank & Trust first reported a position in Allergan Inc in Q2 2015 and held it in 1 quarter.
  • Parkside Financial Bank & Trust's Allergan Inc position peaked at $275K in Q2 2015.
  • 27 funds tracked by Wall St. Rank held Allergan Inc as of Q3 2015.

Based on Parkside Financial Bank & Trust's 13F filing for Q3 2015, filed 6 Nov 2015.